Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Elucidating genotype-phenotype relationships in novel kidney disease genes

EF 2020-21

Résumé
Chronic kidney disease affects approximately one in ten Canadians and puts an enormous strain on the public health care system. Genetic causes of chronic kidney disease account for up to 30% of cases in children and about 10% of cases in adults. Several kidney disease genes have been identified, but many are still unknown. Genetic kidney disease in children is particularly devastating, often presenting with an unremitting course towards complete loss of kidney function. The treatment options are hemodialysis, to filter toxins out of the blood, or kidney transplantation. While kidney transplants are the better choice, with improved survival, there are not enough donor kidneys available. In 2017, more than 25,000 Canadians required treatment with dialysis, while more than 200 patients died while waiting for an organ transplant. This highlights the urgent need to identify patients at risk of chronic kidney disease and to develop new therapies that prevent progression to complete renal failure. My proposed research project at the McGill University Health Centre aims to improve the diagnosis of genetic kidney disease and to improve the understanding of these disease mechanisms. Our goal is to elucidate the role of a newly identified kidney-disease gene using patient-derived cells and zebrafish animal models. These models can then be used to screen for new drug therapies. We expect this work to lay a foundation for the development of new treatment options for hereditary forms of kidney disease in children, for which currently no treatment exists.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449611
Name
Sentell Zachary T
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating genotype-phenotype relationships in novel kidney disease genes
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Model; Chronic Kidney Disease; Drug Screening; Genetics; Kidney Development; Mesangial Cells; Missense Mutations; Nephrotic Syndrome; Whole-Exome Sequencing; Zebrafish
Abstract
Chronic kidney disease affects approximately one in ten Canadians and puts an enormous strain on the public health care system. Genetic causes of chronic kidney disease account for up to 30% of cases in children and about 10% of cases in adults. Several kidney disease genes have been identified, but many are still unknown. Genetic kidney disease in children is particularly devastating, often presenting with an unremitting course towards complete loss of kidney function. The treatment options are hemodialysis, to filter toxins out of the blood, or kidney transplantation. While kidney transplants are the better choice, with improved survival, there are not enough donor kidneys available. In 2017, more than 25,000 Canadians required treatment with dialysis, while more than 200 patients died while waiting for an organ transplant. This highlights the urgent need to identify patients at risk of chronic kidney disease and to develop new therapies that prevent progression to complete renal failure. My proposed research project at the McGill University Health Centre aims to improve the diagnosis of genetic kidney disease and to improve the understanding of these disease mechanisms. Our goal is to elucidate the role of a newly identified kidney-disease gene using patient-derived cells and zebrafish animal models. These models can then be used to screen for new drug therapies. We expect this work to lay a foundation for the development of new treatment options for hereditary forms of kidney disease in children, for which currently no treatment exists.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sentell, Zachary T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~